Analysis of serum lipids, cardiovascular risk, and indication for statin use during nilotinib and imatinib therapy in de novo CML patients – results from real-life prospective study. Issue 2 (28th January 2020) - Horňák, Tomáš; Semerád, Lukáš; Žáčková, Daniela; Weinbergerová, Barbora; Šustková, Zuzana; Procházková, Jiřina; Bělohlávková, Petra; Stejskal, Lukáš; Rohoň, Peter; Faber, Edgar; Žák, Pavel; Mayer, Jiří; et al.